BRAF and melanoma: However, dysregulation of the B-RAF gene via amplification or hyper-activation of the ser/thr protein kinase B-Raf protein (B-RafV600E) in the Ras/Raf/Erk signaling pathways has been associated with acquisition of highly aggressive metastatic nature and poor prognosis in 80% of melanoma [14].